Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Chen Yu reported a 9.99% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Chen Yu reported a 9.99% stake in Vistagen Therapeutics, Inc., 4,100,029 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 4,100,029
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP I, LLC | 2.60% | 1,025,007 |
| TCG Crossover Fund I, L.P. | 2.60% | 1,025,007 |
| TCG Crossover GP II, LLC | 7.60% | 3,075,022 |
| TCG Crossover Fund II, L.P. | 7.60% | 3,075,022 |
| Chen Yu | 9.99% | 4,100,029 |
Source
Related
- Vistagen Therapeutics, Inc.
- TCG Crossover GP II, LLC
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026